Viemed Healthcare Announces Date and Time for Conference Call
LAFAYETTE, La., July 20, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Wednesday, August 3, 2022 at 11:00 a.m. ET.
Interested parties may participate in the call by dialing:
877-407-6176 (US Toll-Free)201-689-8451 (International)
Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail [email protected] by 12:00 p.m. ET Tuesday, August 2, 2022.
Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=nCv1tRHb
Following the live call, a replay will be available in the Investor Relations section of the Company’s website, www.viemed.com.
ABOUT VIEMED HEALTHCARE, INC.
Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting edge technology. Visit our website at www.viemed.com.
For further information, please contact:
Glen AkselrodBristol Capital905-326-1888[email protected]
Todd ZehnderChief Operating OfficerViemed Healthcare, Inc.337-504-3802[email protected]
Source: Viemed Healthcare, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EchoStar Announces Financial Results for the Three and Six Months Ended June 30, 2026
- Heineken N.V. reports the progress of transactions under its current share buyback programme
- Heineken Holding N.V. reports transactions under its current share buyback programme
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share